中文 | English
Return
Total: 9 , 1/1
Show Home Prev Next End page: GO
Author:( Guilan QUAN)

1.Improving the dissolution rate of poorly water-soluble resveratrol by the ordered mesoporous silica.

Guilan QUAN ; Bao CHEN ; Zhouhua WANG ; Han WU ; Xintian HUANG ; Linna WU ; Chuanbin WU

Acta Pharmaceutica Sinica 2012;47(2):239-43

2.Preparation and release behaviour of mesoporous silica/ethylcellulose sustained-release mini-matrix.

Qiaoli WU ; Guilan QUAN ; Yu HONG ; Linna WU ; Youmei ZENG ; Ge LI ; Xin PAN ; Chuanbin WU

Acta Pharmaceutica Sinica 2015;50(4):492-9

3.Recent advances in microneedles-mediated transdermal delivery of protein and peptide drugs.

Ting LIU ; Minglong CHEN ; Jintao FU ; Ying SUN ; Chao LU ; Guilan QUAN ; Xin PAN ; Chuanbin WU

Acta Pharmaceutica Sinica B 2021;11(8):2326-2343

4.Mesoporous silica nanoparticles for drug and gene delivery.

Yixian ZHOU ; Guilan QUAN ; Qiaoli WU ; Xiaoxu ZHANG ; Boyi NIU ; Biyuan WU ; Ying HUANG ; Xin PAN ; Chuanbin WU

Acta Pharmaceutica Sinica B 2018;8(2):165-177

5.Tailored core‒shell dual metal-organic frameworks as a versatile nanomotor for effective synergistic antitumor therapy.

Biyuan WU ; Jintao FU ; Yixian ZHOU ; Sulan LUO ; Yiting ZHAO ; Guilan QUAN ; Xin PAN ; Chuanbin WU

Acta Pharmaceutica Sinica B 2020;10(11):2198-2211

6.A homogenous nanoporous pulmonary drug delivery system based on metal-organic frameworks with fine aerosolization performance and good compatibility.

Yixian ZHOU ; Boyi NIU ; Biyuan WU ; Sulan LUO ; Jintao FU ; Yiting ZHAO ; Guilan QUAN ; Xin PAN ; Chuanbin WU

Acta Pharmaceutica Sinica B 2020;10(12):2404-2416

7.Efficacy and safety of Omalizumab for the treatment of pediatric allergic asthma: a retrospective multicenter real-world study in China

Li XIANG ; Baoping XU ; Huijie HUANG ; Mian WEI ; Dehui CHEN ; Yingying ZHAI ; Yingju ZHANG ; Dan LIANG ; Chunhui HE ; Wei HOU ; Yang ZHANG ; Zhimin CHEN ; Jingling LIU ; Changshan LIU ; Xueyan WANG ; Shan HUA ; Ning ZHANG ; Ming LI ; Quan ZHANG ; Leping YE ; Wei DING ; Wei ZHOU ; Ling LIU ; Ling WANG ; Yingyu QUAN ; Yanping CHEN ; Yanni MENG ; Qiusheng GE ; Qi ZHANG ; Jie CHEN ; Guilan WANG ; Dongming HUANG ; Yong YIN ; Mingyu TANG ; Kunling SHEN

Chinese Journal of Applied Clinical Pediatrics 2023;38(1):64-71

8.Membrane-disruptive peptides/peptidomimetics-based therapeutics: Promising systems to combat bacteria and cancer in the drug-resistant era.

Liming LIN ; Jiaying CHI ; Yilang YAN ; Rui LUO ; Xiaoqian FENG ; Yuwei ZHENG ; Dongyi XIAN ; Xin LI ; Guilan QUAN ; Daojun LIU ; Chuanbin WU ; Chao LU ; Xin PAN

Acta Pharmaceutica Sinica B 2021;11(9):2609-2644

9.Synergistic immunoreaction of acupuncture-like dissolving microneedles containing thymopentin at acupoints in immune-suppressed rats.

Qian ZHANG ; Chuncao XU ; Shiqi LIN ; Huanbin ZHOU ; Gangtao YAO ; Hu LIU ; Lili WANG ; Xin PAN ; Guilan QUAN ; Chuanbin WU

Acta Pharmaceutica Sinica B 2018;8(3):449-457

Sort by Result Analysis

Display Mode

Output Records




File Type





Total: 9 , 1/1 Show Home Prev Next End page: GO